INCY

Transfer...
Symbol:



NASDAQ / Sector: Healthcare / Sub-Sector: Biotechnology / Stock Type: Speculative Growth
# of Employee: 900 / Fiscal Year End: 2016-12-31 / Stock Type: Mid Growth
USD / Exchange Rate: 1 at 2016-11-22 / Estimation: $Confidential / / $

Incyte Corp is a biopharmaceutical company. It discovers, develops and commercializes proprietary small molecule drugs to treat serious unmet medical needs, mainly in oncology.

Competitors | AnnualReport

Competitors List | Key Matrix Details

AMGN | NVO | GILD | CELG | BIIB | SHPG | VRTX | REGN | ALXN | GRFS | NKTR | AKCA |

Finance Highlights

Key Ratio Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##FinanceKeyRatioHighlights}

Key Ratio Trend

{##FinanceKeyRatioTrend}

Income Statement Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2014-06-25Quarter99,582k187k11,406k-36,873k-36,873k167,914,k99.80%-37.00%-37.00%
2014-09-25Quarter198,147k221k11,463k59,293k59,293k189,046,k99.90%29.90%29.90%
2014-12-25Quarter123,973k2,428k12,516k-36,943k-36,943k169,924,k98.00%-29.80%-29.80%
2015-03-25Quarter159,275k2,974k12,687k-18,359k-18,359k172,070,k98.10%-11.50%-11.50%
2015-06-25Quarter162,984k6,254k11,494k9,294k9,294k186,493,k96.20%5.70%5.70%
2015-09-25Quarter187,611k8,040k11,209k-39,582k-39,582k181,387,k95.70%-21.10%-21.10%
2015-12-25Quarter243,881k9,704k10,213k55,176k55,176k217,074,k96.00%22.60%22.60%
2016-03-25Quarter263,464k6,005k10,134k24,047k24,047k192,625,k97.70%9.10%9.10%
2016-06-25Quarter246,288k12,367k9,662k34,425k34,425k193,015,k95.00%14.00%14.00%
2016-09-25Quarter269,469k20,205k9,479k36,877k36,877k194,265,k92.50%13.70%13.70%
2016-12-25Quarter326,498k19,623k9,470k8,873k8,873k195,238,k94.00%2.70%2.70%
2017-03-25Quarter384,082k14,824k5,939k-187,083k-187,083k195,260,k96.10%-48.70%-48.70%
2017-06-25Quarter326,444k20,260k384k-12,484k-12,484k205,141,k93.80%-3.80%-3.80%
2017-09-25Quarter381,534k22,036k204k36,054k36,054k212,610,k94.20%9.40%9.40%
2017-12-25Quarter444,156k22,380k373k-149,629k-149,629k211,123,k95.00%-33.70%-33.70%
2018-03-25Quarter382,282k18,106k385k-41,140k-41,140k211,681,k95.30%-10.80%-10.80%
2018-06-25Quarter521,516k24,856k398k52,394k52,394k215,103,k95.20%10.00%10.00%
2018-09-25Quarter449,683k24,795k405k29,176k29,176k215,964,k94.50%6.50%6.50%
2018-12-25Quarter528,402k26,343k355k69,063k69,063k215,992,k95.00%13.10%13.10%
2019-03-25Quarter497,857k22,588k335k102,312k102,312k217,061,k95.50%20.60%20.60%
2019-06-25Quarter529,932k29,406k316k105,318k105,318k217,483,k94.50%19.90%19.90%

Income Statement Trend

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2015-06-25Quarter63.67%3,244.39%0.77%-125.21%-125.21%11.06%-3.61%-115.41%-115.41%
2015-09-25Quarter-5.32%3,538.01%-2.22%-166.76%-166.76%-4.05%-4.20%-170.57%-170.57%
2015-12-25Quarter96.72%299.67%-18.40%-249.35%-249.35%27.75%-2.04%-175.84%-175.84%
2016-03-25Quarter65.41%101.92%-20.12%-230.98%-230.98%11.95%-0.41%-179.13%-179.13%
2016-06-25Quarter51.11%97.75%-15.94%270.40%270.40%3.50%-1.25%145.61%145.61%
2016-09-25Quarter43.63%151.31%-15.43%-193.17%-193.17%7.10%-3.34%-164.93%-164.93%
2016-12-25Quarter33.88%102.22%-7.28%-83.92%-83.92%-10.06%-2.08%-88.05%-88.05%
2017-03-25Quarter45.78%146.86%-41.40%-877.99%-877.99%1.37%-1.64%-635.16%-635.16%
2017-06-25Quarter32.55%63.82%-96.03%-136.26%-136.26%6.28%-1.26%-127.14%-127.14%
2017-09-25Quarter41.59%9.06%-97.85%-2.23%-2.23%9.44%1.84%-31.39%-31.39%
2017-12-25Quarter36.04%14.05%-96.06%-1,786.34%-1,786.34%8.14%1.06%-1,348.15%-1,348.15%
2018-03-25Quarter-0.47%22.14%-93.52%-78.01%-78.01%8.41%-0.83%-77.82%-77.82%
2018-06-25Quarter59.76%22.69%3.65%-519.69%-519.69%4.86%1.49%-363.16%-363.16%
2018-09-25Quarter17.86%12.52%98.53%-19.08%-19.08%1.58%0.32%-30.85%-30.85%
2018-12-25Quarter18.97%17.71%-4.83%-146.16%-146.16%2.31%0.00%-138.87%-138.87%
2019-03-25Quarter30.23%24.75%-12.99%-348.69%-348.69%2.54%0.21%-290.74%-290.74%
2019-06-25Quarter1.61%18.31%-20.60%101.01%101.01%1.11%-0.74%99.00%99.00%


Balance Sheet Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2016-12-25Quarter419,467k1,638,597k1,219,130k994,178k273,501k945,629k.344.275
2017-03-25Quarter965,934k1,607,347k641,413k819,175k304,716k336,697k1.506.372
2017-06-25Quarter1,026,835k1,639,443k612,608k844,803k293,161k319,447k1.676.347
2017-09-25Quarter1,757,750k2,374,301k616,551k1,541,322k319,935k296,616k2.851.208
2017-12-25Quarter1,630,629k2,302,582k671,953k1,504,854k375,396k296,557k2.427.249
2018-03-25Quarter1,628,044k2,306,012k677,968k1,469,555k381,072k296,896k2.401.259
2018-06-25Quarter1,732,923k2,397,157k664,234k1,598,084k368,239k295,995k2.609.230
2018-09-25Quarter1,802,899k2,519,947k717,048k1,700,359k422,489k294,559k2.514.248
2018-12-25Quarter1,925,967k2,645,762k719,795k1,832,254k425,277k294,518k2.676.232
2019-03-25Quarter2,085,567k2,754,161k668,594k1,904,500k364,515k304,079k3.119.191

Balance Sheet Trend

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2017-12-25Quarter288.74%40.52%-44.88%51.37%37.26%-68.64%605.52%-9.45%
2018-03-25Quarter68.55%43.47%5.70%79.39%25.06%-11.82%59.43%-30.38%
2018-06-25Quarter68.76%46.22%8.43%89.17%25.61%-7.34%55.67%-33.72%
2018-09-25Quarter2.57%6.13%16.30%10.32%32.05%-0.69%-11.82%19.23%
2018-12-25Quarter18.11%14.90%7.12%21.76%13.29%-0.69%10.26%-6.83%
2019-03-25Quarter28.10%19.43%-1.38%29.60%-4.34%2.42%29.90%-26.25%


Cash Flow Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##CashFlowHighlights}

Cash Flow Trend

{##CashFlowTrend}


Finance Detail

Income Statement Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Balance Sheet Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Cash Flow Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top




Note